Temporomandibular Joint Disorders

北京和上海 2024年3月7日 /美通社/ -- 3月3日，中国整形美容协会口腔整形美容分会换届大会顺利召开。经过选举，大会产生了新一届理事会，泰康拜博口腔沈刚教授当选为中国整形美容协会口腔整形美容分会副会长，泰康拜博口腔郭涛博士、徐子卿博士当选为理事。 沈刚教授及团队成员当选为中国整形美容协会口腔整形美容分会副会长、理事 中国整形美容协会口腔整形美容分会凝聚全国从事口腔整形美容技术专业的工作者，以学术交融为宗旨，开展交叉学科研究、联合治疗和技术交流，推动行业的共同发展。泰康拜博沈刚教授及团队成员当选为分会副会长及理事，将充分发挥其行业领军地位，推动调整和规范行业行为，维护从业者的合法权益，树立行业风范，推动中国口腔整形美容技术健康发展。 泰康拜博沈刚教授深耕正畸领域基础研究、临床应用与创新技术研究三十余年，是中国口腔正畸发展的中坚技术人才，有着众多学术成就和荣誉。作为泰康拜博口腔集团级专家、执行医疗总裁、正畸专业学术委员会主任委员、首席口腔正畸专家、上海泰康拜博昌仁口腔医院院长，沈刚教授充分展现其学术领军地位，在提升泰康拜博正畸治疗水平的同时，也带领团队取得了丰硕的学术成果。 郭涛博士、徐子卿博士是泰康拜博沈刚正畸团队的核心骨干，在医教研各个领域均取得了一系列成果。沈刚教授领衔的正畸团队潜心临床创新、深耕技术研发，共获得12项国家发明专利、18项新型实用专利。是突面畸形分类诊断、下颌骨形态学分析、拔牙与否十大关系等理念的创立者，也是SGTB矫形、颌骨生长型重塑、正雅GS颌位重建、舌侧无形矫治、TMJ骨组织诱导改建及TMD正畸介入治疗等正畸临床核心技术的首创者或引领者，在我国现代正畸临床治疗学的理论创新与技术拓展发挥重要影响，形成了包括基础理论、机制循证、装置设计、临床治疗及疗效评价等各个环节的完整体系，完善了严重畸形正畸治疗方案。这种基于东方人面型特征的矫形治疗，与欧美人常需进行的仅解决牙齿问题的矫治治疗不同，更具有"中国特色"。 泰康拜博始终坚持"技术、学术、服务"并行的发展之路。在专业学科建设和医疗人才培养方面大力投入，汇聚了一批我国口腔行业学术造诣高、学风端正、医德高尚的大咖专家。未来，泰康拜博口腔将持续开展多学科研究和技术交流和新成果分享，尽己之力推动行业进步，服务于更多的患者，为口腔行业健康发展贡献力量 。

北京和上海 2023年10月30日 /美通社/ -- 近日，美国斯坦福大学与爱思唯尔数据库（Elsevier）联合发布了"斯坦福全球前2%顶尖科学家榜单"(Top2% of Scientists on Stanford List )第六版。共有65位中国大陆口腔医学学者入选《全球前2%顶尖科学家年度科学影响力榜单》，泰康拜博正畸专家沈刚教授跻身在榜。该权威榜单肯定了沈刚教授所取得的学术成果在口腔医学领域具有的广泛世界影响力，同时意味着其个人科研能力和杰出贡献充分获得了行业的认可。 泰康拜博沈刚教授入选“2023年度全球前2%顶尖科学家榜单” "全球前2%顶尖科学家榜单"是斯坦福大学与爱思唯尔合作的项目成果，该榜单基于Scopus数据库的引用数据系统分析，统计SSCI、SCI、EI期刊、EI会议等论文，对论文被引次数、h指数、hm指数等进行综合评估。该评估方式比较符合学界的普遍标准，并且其排名分22个学科领域和176个子学科领域，能够比较客观、真实的反映科学家的产出量和学术影响力。 https://jokergoooo.shinyapps.io/top2pct_scientists/ 沈刚教授深耕正畸领域基础研究、临床应用与创新技术研究三十余年，是中国口腔正畸发展的中坚技术人才，有着众多顶尖学术成就和荣誉。作为泰康拜博口腔集团级专家、执行医疗总裁、正畸专业学术委员会主任委员、首席口腔正畸专家、上海泰康拜博昌仁口腔医院院长，沈刚教授充分展现其学术领军地位，在提升泰康拜博正畸治疗水平的同时，也带领团队取得了丰硕的学术成果。 沈刚领衔的正畸团队潜心临床创新、深耕技术研发，共获得12项国家发明专利、18项新型实用专利。是突面畸形分类诊断、下颌骨形态学分析、拔牙与否十大关系等理念的创立者，也是SGTB矫形、颌骨生长型重塑、正雅GS颌位重建、舌侧无形矫治、TMJ骨组织诱导改建及TMD正畸介入治疗等正畸临床核心技术的首创者或引领者，在我国现代正畸临床治疗学的理论创新与技术拓展发挥重要影响，形成了包括基础理论、机制循证、装置设计、临床治疗及疗效评价等各个环节的完整体系，完善了严重畸形正畸治疗方案。这种基于东方人面型特征的矫形治疗，与欧美人常需进行的仅解决牙齿问题的矫治治疗不同，更具有"中国特色"。 泰康拜博始终坚持"技术、学术、服务"并行的发展之路。在专业学科建设和医疗人才培养方面大力投入，汇聚了一批我国口腔行业学术造诣高、学风端正、医德高尚的大咖专家。在集团级专家的带领下，泰康拜博通过完备的人才培养机制，加强校企合作，构建人才孵化路径，为口腔行业培养了大批专业人才。不仅如此，泰康拜博专家学者深耕领域，不断创新，在科研专著、临床竞赛等方面均取得了重要成果。 泰康拜博口腔打造了良好的科研创新环境，沈刚教授入选"2023年度全球前2%顶尖科学家榜单"将进一步激发科研创新内生动力，持续深挖研究口腔医学创新，不断推进口腔医疗行业发展。

The homologous-use application validated by Dr. Ryan Robinson and NP Rachel Reynolds sets a precedent for non-surgical allograft application. PENSACOLA, Fla., Oct. 26, 2023 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a case study demonstrating new care advancements using its Wharton's Jelly allografts in the supplementation of Temporomandibular Joint (TMJ) defects. The case study titled "Single-Center Retrospective Study of Flowable Umbilical Cord Tissue Allograft Application in Temporomandibular Joint Defects: An Investigative Study," was published by Walsh Medical Media and can be accessed in its entirety here. Board-certified sleep medicine and craniofacial pain specialists Dr. Ryan Robinson and NP Rachel Reynolds of The Pain and Sleep Therapy Center presented a novel case series studying the application of Wharton's Jelly, an umbilical cord connective tissue, to the structural tissue defect of the temporomandibular joint. This homologous use application validated by Robinson and Reynolds sets a precedent for non-surgical allograft application. "We've seen a decrease in terms of healing time for patients when we've compared it to other types of injections that we've used previously for patients with temporomandibular joint dysfunction (TMD). We've also seen improvement in outcomes for patients who've been utilizing Wharton's Jelly in conjunction with other types of modalities that we've used for these patients," shared NP Rachel Reynolds. Nearly 10 million patients suffer from TMD in the United States each year. These patients often experience symptoms ranging from joint arthralgia, displacement, degenerative arthritis, limited and painful mouth opening, painful subluxation of the joint, joint clicking, and referred pain to the periauricular area or head and neck muscles. Although there are many treatments for TMD, therapy specific to degenerative pathology of the TMJ disc itself is limited in scope and therapeutic effect. Standard treatment includes simply resting the jaw muscles and avoiding use, massage, physical therapy, medication management, and, when all else fails, surgery. The rising annual number of surgeries and high out-of-pocket costs for patients, overall treatment costs ranging from 5,000-50,000 USD, are enough to implement conservative protocols alternative to invasive surgical repair of the TMJ. "Today, we see many physicians who are wary about treating TMJ and often revert to standard surgical treatments. Showing the outcomes that we have for patients will hopefully help to bolster more physicians to join us in using more conservative treatments. Our patients deserve more options," concluded Reynolds. The five patients in this case series presented with chronic refractory TMD, specifically from severe degeneration of the structural tissues within the joint, and had failed standard-of-care practices for at least three months. After one application of Regenative's Wharton's Jelly allograft, the patient's pain improved by an average of 75% after 90 days. "A few years ago, we started using PRF (platelet-rich fibrin) therapy in the jaw joint, and we thought that was revolutionary. We have seen amazing results; however, the protocol involves additional technology like a centrifuge and consists of multiple rounds of injections to get the desired outcome. It also subjectively eliminates some patients from treatment who are opposed to blood draws on themselves. With Wharton's Jelly, there is only one injection, which makes the application much easier, more convenient, and less invasive to the patient. What's most exciting is the results we are seeing! We're seeing much better patient outcomes than any other modality we've ever treated. We're really excited to continue the use of Wharton's Jelly in our Pain and Sleep clinic, and it soon becoming a routine standard for our patients who can benefit," shared Dr. Ryan Robinson. To advance the necessary research and fill the need for non-surgical alternatives, Regenative has been tracking data in its comprehensive retrospective data repository in which physicians across specialties submit patient data as they track patient outcomes up to 120 days after the patient receives an application of Regenative's products, like its Wharton's Jelly allografts. Regenative has collected data from clinics nationwide on Wharton's Jelly homologous-use applications around the body. Still, very few have documented data on the jaw joint, and Regenative is excited to highlight this unique procedure in the first of many publications on regenerative orthodontic medicine. "Given the high incidence rate and few effective treatment options for defects in the Temporomandibular Joint, this study aims to provide a new, promising alternative intervention for patients who have failed all other standard-of-care treatments. This is just one of many homologous-use applications in regenerative medicine to improve patient outcomes," shared Regenative Labs CEO Tyler Barrett. Barrett and his team hope to enlist physicians to take part in studies regarding uncovered uses. Physicians will have their outcomes highlighted, furthering the understanding of regenerative medicine and uncovering new applications for this groundbreaking field of medicine. "We're doing the research at Regenative, and the results are very promising. We are calling on all physicians across the country to engage with us to advance the field of regenerative medicine," Barrett concluded. Contact Regenative to get your practice involved today. Read the full case study here. About Regenative Labs: Regenative Labs produces regenerative medicine products to address the root cause of a patient's conditions using Wharton's Jelly innovations rather than masking the pain with other treatments. Regenative Labs works closely with scientists, physicians, hospitals, and surgery centers to constantly monitor and improve patient progress and outcomes for new product development. Formed by veteran industry professionals familiar with the daily challenges of innovations in healthcare, the company provides non-addictive, non-invasive options for patients. Regenative Labs' expert product research and development team complies with FDA guidelines of minimal manipulation for homologous use. The company adheres to AATB and FDA guidelines. Learn more at Regenative's website: About Dr. Ryan Robinson: Dr. Robinson is Delaware's first and only doctor triple-boarded in Craniofacial Pain and Dental Sleep Medicine. After many years of treating the airway in his general dental practice, Dr. Robinson decided to open up a specialty practice to address the needs of the community. This new practice, called The Pain and Sleep Therapy Center of Delaware Valley, focuses on finding the origin of the problem as opposed to treating it with medications and "band-aid" fixes that have become so routine in today's medical system. Learn more at Pain and Sleep Therapy Center's website: About Rachel Reynolds: Rachel is a Family Nurse Practitioner (FNP) who joined the Pain and Sleep team in July 2021. Originally, Rachel is from upstate New York, where she completed her Bachelor of Nursing and Master of Nursing at Binghamton University. Prior to completing her Master's, Rachel worked in Neurology as a registered nurse, focusing on patients who dealt with chronic pain and headaches. Upon moving to Delaware, Rachel completed a fellowship in Primary Care with Christiana Care. During her fellowship, she identified her passion for comprehensive patient care, which resulted in her devotion to identifying the root cause of her patient's issues. Upon identifying a need for nutritional guidance for our patient population, Rachel acquired a certification in nutrition from the University of Stanford. Rachel is also completing a second master's degree program in Psychiatry at this time to better assist patients and provide a more comprehensive scope of practice. Learn more at Pain and Sleep Therapy Center's website: SOURCE Regenative Labs